These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38109062)

  • 1. Diagnostic and Therapeutic Radiopharmaceuticals: A "Hot" Topic.
    Lindsley CW; Müller CE; Bongarzone S
    J Med Chem; 2023 Dec; 66(24):16457-16463. PubMed ID: 38109062
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter from the editors: positron emission tomography radiopharmaceuticals-current status.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography/CT after yttrium-90 radioembolization: current and future applications.
    Gates VL; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Aug; 24(8):1153-5. PubMed ID: 23885913
    [No Abstract]   [Full Text] [Related]  

  • 4. An Introduction to Newer PET Diagnostic Agents and Related Therapeutic Radiopharmaceuticals.
    Mantel E; Williams J
    J Nucl Med Technol; 2019 Sep; 47(3):203-209. PubMed ID: 31019034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there new possibilities for the use of positron emission tomography in oncology?
    Zdravkovic D; Zdravkovic M; Randjelovic T; Bilanovic D; Granic M
    J BUON; 2014; 19(1):318. PubMed ID: 24659684
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-based radiopharmaceuticals for imaging and therapy.
    Holland JP
    J Labelled Comp Radiopharm; 2018 Jul; 61(9):610. PubMed ID: 29771470
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of adverse events to radiopharmaceuticals from 2007 to 2011.
    Silberstein EB
    J Nucl Med; 2014 Aug; 55(8):1308-10. PubMed ID: 24876206
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tarantal AF
    Hum Gene Ther; 2020 Dec; 31(23-24):1224-1225. PubMed ID: 33337271
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer.
    Sakulpisuti C; Charoenphun P; Chamroonrat W
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
    Krasikova RN; Kodina GE
    Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of aortic root inflammation in a patient with systemic vasculitis using F-18 FDG positron emission tomography.
    Ha JW; Lee JD; Chang BC; Chung N
    Heart; 2006 Dec; 92(12):1789. PubMed ID: 17105882
    [No Abstract]   [Full Text] [Related]  

  • 12. 86Y based PET radiopharmaceuticals: radiochemistry and biological applications.
    Nayak TK; Brechbiel MW
    Med Chem; 2011 Sep; 7(5):380-8. PubMed ID: 21711222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
    Allott L; Aboagye EO
    Mol Pharm; 2020 Jul; 17(7):2245-2259. PubMed ID: 32433888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unconventional nuclides for radiopharmaceuticals.
    Holland JP; Williamson MJ; Lewis JS
    Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals.
    Ballinger JR
    Semin Nucl Med; 2015 Sep; 45(5):470-8. PubMed ID: 26278857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography computed tomography in oncology.
    Drake B; Cook GJ
    Br J Hosp Med (Lond); 2011 Nov; 72(11):631-7. PubMed ID: 22083005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
    Herrero Álvarez N; Bauer D; Hernández-Gil J; Lewis JS
    ChemMedChem; 2021 Oct; 16(19):2909-2941. PubMed ID: 33792195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
    Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
    Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational diastolic hypertension with gene mutation-related pheochromocytoma positive at ¹⁸F-DOPA PET/CT: diagnostic and therapeutic implications.
    Mazza A; Armigliato M; Ferretti A; Schiavon L; Zorzan S; Casiglia E; Marzola MC; Tadayyon S; Chondrogiannis S; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):111-2. PubMed ID: 23153989
    [No Abstract]   [Full Text] [Related]  

  • 20. A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.
    Verburg FA; Luster M
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1611-1613. PubMed ID: 28677048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.